PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsanxiety disorders
MeSH D001008 - anxiety disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001523:Mental disorders
0 Companies
0 Drugs
Success rate
D001008: 
Anxiety disorders
D001010:Separation anxiety
0 Companies
0 Drugs
Success rate
D009449:Neurocirculatory asthenia
0 Companies
0 Drugs
Success rate
D009497:Neurotic disorders
0 Companies
0 Drugs
Success rate
D009771:Obsessive-compulsive disorder
$
Success rate
D010698:Phobic disorders
$
Success rate
D016584:Panic disorder
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyDiphenhydramine Diphenhydramine  1982-01-01   
Able LaboratoriesHydroxyzine Hydroxyzine  2004-07-22   
Accord HealthcarePregabalin Pregabalin Accord  2015-08-28   
Buspirone Buspirone  2014-12-30   
Ajanta PharmaDuloxetine Duloxetine  2017-01-06   
Doxepin Doxepin  2019-09-13   
AkornMidazolam Midazolam  2003-09-04   
Diphenhydramine Diphenhydramine  1990-09-28   
Alembic PharmaceuticalsDuloxetine Duloxetine  2014-06-09   
Doxepin Doxepin  2021-04-21   
Alkem LaboratoriesDuloxetine Duloxetine  2015-08-26   
AllerganDuloxetine Duloxetine  2013-12-17   
Lorazepam Lorazepam  1987-03-23   
Doxepin Doxepin  1987-03-04   
Oxazepam Oxazepam  1987-04-21   
Diphenhydramine Diphenhydramine  1982-01-01   
Hydroxyzine Hydroxyzine  1994-03-18   
Hydroxyzine Hydroxyzine Pamoate  1991-07-31   
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
59%
13/22
Phase 2
67%
26/39
Phase 3
41%
60/148
Approved: 29Overall Success rate: 16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
1
2
3
4
5
6
...
11
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use